BGLAP and ovarian cancer: To further evaluate our assay concept, we designed a drug library consisting of 58 different small molecules relevant to ovarian cancer treatment covering a five-point concentration range for each drug, referred to here as the OC repurposing library (Fig. 1c, for full description of the OC library see Supplementary Table 2).